Medical Image Segmentation on CHD 68 patients total (test)
77.4DicePCL
Evaluation results
| Method | Links | |
|---|---|---|
| PCLM (Number of patients)=51, Validation=5-fold cross-validation2021.06 | 77.4 | |
| GCLM (Number of patients)=51, Validation=5-fold cross-validation2021.06 | 76.6 | |
| PIRLM (Number of patients)=51, Validation=5-fold cross-validation2021.06 | 76.1 | |
| SimCLRM (Number of patients)=51, Validation=5-fold cross-validation2021.06 | 75.6 | |
| RandomM (Number of patients)=51, Validation=5-fold cross-validation2021.06 | 75.4 | |
| RotationM (Number of patients)=51, Validation=5-fold cross-validation2021.06 | 74.9 | |
| PCLM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 73.5 | |
| GCLM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 72.5 | |
| PCLM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 71.6 | |
| PIRLM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 71.4 | |
| SimCLRM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 69.9 | |
| GCLM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 69.7 | |
| RandomM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 69.3 | |
| RotationM (Number of patients)=30, Validation=5-fold cross-validation2021.06 | 69.1 | |
| PCLM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 68.6 | |
| PIRLM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 67.4 | |
| GCLM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 66.9 | |
| SimCLRM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 66.6 | |
| PCLM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 66.1 | |
| RandomM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 65.8 | |
| PIRLM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 65.8 | |
| RotationM (Number of patients)=20, Validation=5-fold cross-validation2021.06 | 65.1 | |
| GCLM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 64.6 | |
| SimCLRM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 63.1 | |
| RandomM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 62.7 | |
| RotationM (Number of patients)=15, Validation=5-fold cross-validation2021.06 | 62.5 | |
| PIRLM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 61.7 | |
| PCLM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 60 | |
| SimCLRM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 59.9 | |
| RandomM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 58.4 | |
| RotationM (Number of patients)=10, Validation=5-fold cross-validation2021.06 | 57.5 | |
| GCLM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 56.4 | |
| SimCLRM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 51.5 | |
| RandomM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 50.8 | |
| PIRLM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 50.4 | |
| RotationM (Number of patients)=6, Validation=5-fold cross-validation2021.06 | 48.8 | |
| PCLM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 35.6 | |
| GCLM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 25.5 | |
| PIRLM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 19.6 | |
| SimCLRM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 19.2 | |
| RandomM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 18.4 | |
| RotationM (Number of patients)=2, Validation=5-fold cross-validation2021.06 | 17.1 |